Genetic polymorphisms in MDR1, CYP3A4 and CYP3A5 genes in a Ghanaian population: a plausible explanation for altered metabolism of ivermectin in humans?

BMC Medical Genetics
William KudziJeremy J Mills

Abstract

Ivermectin, a substrate of multidrug resistance (MDR1) gene and cytochrome P450 (CYP) 3A4, has been used successfully in the treatment of onchocerciasis in Ghana. However, there have been reports of suboptimal response in some patients after repeated treatment. Polymorphisms in host MDR1 and CYP3A genes may explain the observed suboptimal response to ivermectin. We genotyped relevant functional polymorphisms of MDR1 and CYP3A in a random sample of healthy Ghanaians and compared the data with that of ivermectin-treated patients with a view to exploring the relationship between suboptimal response to ivermectin and MDR1 and CYP3A allelic frequencies. Using PCR-RFLP, relevant polymorphic alleles of MDR1 and CYP3A4 genes were analysed in 204 randomly selected individuals and in 42 ivermectin treated patients. We recorded significantly higher MDR1 (3435T) variant allele frequency in suboptimal responders (21%) than in patients who responded to treatment (12%) or the random population sample (11%). CYP3A4*1B, CYP3A5*3 and CYP3A5*6 alleles were detected at varied frequencies for the sampled Ghanaian population, responders and suboptimal responders to ivermectin. CYP3A5*1/CYP3A5*1 and CYP3A5*1/CYP3A5*3 genotypes were also found to be s...Continue Reading

References

Nov 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·F ThiebautM C Willingham
Jan 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·C Cordon-CardoJ R Bertino
Jan 1, 1995·World Health Organization Technical Report Series
May 1, 1994·The Histochemical Journal·A MacFarlandC K Pearson
May 9, 1998·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Z ZengR W Wang
Aug 27, 1998·Journal of the National Cancer Institute·T R RebbeckS B Malkowicz
Oct 28, 1998·Proceedings of the National Academy of Sciences of the United States of America·C A FelixT R Rebbeck
Mar 15, 2000·Proceedings of the National Academy of Sciences of the United States of America·S HoffmeyerU Brinkmann
Sep 25, 2001·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·A Ayrton, P Morgan
Dec 12, 2001·Pharmacogenetics·E HustertL Wojnowski
Aug 22, 2002·Clinical Pharmacology and Therapeutics·Yasuo KurataKenji Otsubo
Sep 14, 2002·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Ina KochLeszek Wojnowski
Oct 3, 2002·Annual Review of Pharmacology and Toxicology·Matthias SchwabMartin F Fromm
Oct 31, 2002·Advanced Drug Delivery Reviews·Jatinder K LambaKenneth E Thummel
Feb 28, 2003·Filaria Journal·Yankum DadzieDonald Hopkins
May 21, 2003·European Journal of Clinical Pharmacology·C BalramEdmund J D Lee
Jul 2, 2003·Pharmacogenomics·Toshiyuki SakaedaKatsuhiko Okumura
Aug 2, 2003·Pharmacogenetics·Deanna L KroetzUNKNOWN Pharmacogenetics of Membrane Transporters Investigators
Sep 19, 2003·International Journal of Antimicrobial Agents·Dominique KerboeufGeorg von Samson-Himmelstjerna
Nov 18, 2003·British Journal of Clinical Pharmacology·Aurel C AllabiYves Horsmans
Jan 30, 2004·Clinical Pharmacology and Therapeutics·Catia MarzoliniRichard B Kim
May 26, 2004·International Journal of Pharmaceutics·L Z BenetC Y Wu
Dec 15, 2004·Hypertension·Herbert HoMyron H Weinberger
May 11, 2005·BMC Medical Genetics·Adam A GarsaSharon Marsh
Jul 5, 2005·Molecular and Biochemical Parasitology·Bernadette F ArdelliRoger K Prichard
Oct 13, 2006·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Su-Jun LeeRon H N van Schaik
Sep 26, 2008·Annals of Tropical Medicine and Parasitology·B Boatin
Oct 12, 2010·Drug Metabolism and Pharmacokinetics·Joanne Siok Liu LimBalram Chowbay

❮ Previous
Next ❯

Citations

Aug 13, 2013·DNA and Cell Biology·Yaya KassogueSellama Nadifi
Aug 23, 2011·Ghana Medical Journal·Jairo A Garcia A, Lewis R Roberts
Mar 5, 2014·Expert Opinion on Drug Metabolism & Toxicology·Collet DandaraCollen Masimirembwa
Apr 18, 2013·Drug Metabolism Reviews·Marco AlessandriniMichael Sean Pepper
Jan 8, 2016·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Zhengshuai ChenChao Chen
Nov 29, 2011·Clinica Chimica Acta; International Journal of Clinical Chemistry·Alexy RosalesLuis A Salazar
Nov 24, 2016·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Cord SunderkötterHenning Hamm
Nov 24, 2016·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Cord SunderkötterHenning Hamm
Jun 2, 2016·Antimicrobial Agents and Chemotherapy·Cécile MénezAnne Lespine
Dec 20, 2018·British Journal of Clinical Pharmacology·Urs DuthalerFelix Hammann
Oct 12, 2012·Molecular Biology Reports·Abdullah M Al-MohizeaMohammed S Al-Dosari
Apr 18, 2020·The British Journal of Dermatology·M E Murdoch
Jan 19, 2018·PLoS Neglected Tropical Diseases·Jose MuñozAlejandro J Krolewiecki
Jan 27, 2021·Pharmacology Research & Perspectives·Phornpimon TiptharaJoel Tarning
Jul 10, 2021·Journal of Medicinal Chemistry·Lovepreet Singh, Kamaljit Singh
Aug 10, 2021·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·H J Weng, T F Tsai

❮ Previous
Next ❯

Software Mentioned

SNPAlyze

Related Concepts

Related Feeds

Anthelmintics (ASM)

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Antiparasitics

Antiparasitics are medications which are indicated for the treatment of parasitic diseases. Discover the latest research on antiparasitics here.